Covered recipient · General Payments record
PURNIMA SAU
Allopathic & Osteopathic Physicians Dermatology Dermatopathology
General Payments · PY2018–2022
$968.39
- Reported across 44 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2022 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $178.69 | 10 |
By paying entity
PY2022 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $71.06 | 3 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $41.07 | 3 |
| Lilly USA, LLC | $38.22 | 2 |
| Galderma Laboratories, L.P. | $15.43 | 1 |
| Amgen Inc. | $12.91 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2022 (10)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $21.67 | 04/27/2022 | Food and Beverage | Undisputed | 01/23/2026 | 891528051 | CMS |
| ABBVIE INC. | $19.80 | 05/16/2022 | Food and Beverage | Undisputed | 01/23/2026 | 891528053 | CMS |
| ABBVIE INC. | $29.59 | 05/24/2022 | Food and Beverage | Undisputed | 01/23/2026 | 891528055 | CMS |
| Amgen Inc. | $12.91 | 05/17/2022 | Food and Beverage | Undisputed | 01/23/2026 | 940049989 | CMS |
| Galderma Laboratories, L.P. | $15.43 | 06/03/2022 | Food and Beverage | Undisputed | 01/23/2026 | 952294809 | CMS |
| Lilly USA, LLC | $20.20 | 02/01/2022 | Food and Beverage | Undisputed | 01/23/2026 | 918220577 | CMS |
| Lilly USA, LLC | $18.02 | 05/02/2022 | Food and Beverage | Undisputed | 01/23/2026 | 918258385 | CMS |
| Novartis Pharmaceuticals Corporation | $13.21 | 02/07/2022 | Food and Beverage | Undisputed | 01/23/2026 | 894328545 | CMS |
| Novartis Pharmaceuticals Corporation | $13.19 | 04/05/2022 | Food and Beverage | Undisputed | 01/23/2026 | 894328551 | CMS |
| Novartis Pharmaceuticals Corporation | $14.67 | 07/18/2022 | Food and Beverage | Undisputed | 01/23/2026 | 894328557 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022
- Generated from
- OP_DTL_GNRL_PGYR2022_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.